Toggle Main Menu Toggle Search

Open Access padlockePrints

CLEC14A correlates with neutrophil infiltration in hepatocellular carcinoma and mediates neutrophil recruitment across liver endothelial cells

Lookup NU author(s): Professor Helen ReevesORCiD, Professor Derek MannORCiD

Downloads


Licence

This work is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0).


Abstract

© 2026 The Author(s). The Journal of Pathology published by John Wiley & Sons Ltd on behalf of The Pathological Society of Great Britain and Ireland. Hepatocellular carcinoma (HCC) is a leading cause of cancer-related deaths globally, and cases are predicted to rise dramatically over the next few years. Overcoming the immune microenvironment in HCC remains a challenge, and innate immune populations such as tumour-associated neutrophils can potentially impair the success of immunotherapy. Elucidating the mechanisms of neutrophil recruitment across liver endothelium could lead to new approaches to boost the efficacy of immunotherapy. CLEC14A is an endothelium-specific receptor regulating sprouting angiogenesis, upregulated in low shear environments. We found CLEC14A to be highly expressed in both HCC vessels and on vasculature during acute liver injury, leading us to hypothesise that CLEC14A may regulate neutrophil recruitment to the liver and HCC. We found that CLEC14A positively correlated with a neutrophil signature and infiltration in public datasets and surgically resected tissue from HCC. Spatial transcriptomics (ST) of CLEC14Ahigh- and CLEC14Alow-expressing tumours confirmed upregulation of myeloperoxidase in CLEC14Ahigh tumours and correlation with other shear-dependent markers but a negative correlation with vascular endothelial growth factor A. To build on our correlation studies, we explored the role of CLEC14A in neutrophil recruitment across liver endothelium. We undertook in vitro recruitment studies with flow-based human liver endothelial assays and in vivo models of neutrophil recruitment. Using siRNA knockdown of CLEC14A and specific blocking antibodies to CLEC14A, we found that CLEC14A knockdown blocked the firm adhesion of neutrophils to liver endothelium, but this was independent of its interaction with its known ligand MMRN2. Finally, we confirmed that Clec14a deficiency led to a significant reduction in neutrophil recruitment across the sinusoids in an ischaemia-reperfusion liver injury model. We unveil a link between the angiogenic receptor CLEC14A and neutrophil recruitment. Targeting of CLEC14A on tumour endothelium is potentially a new approach to regulating neutrophil infiltration in HCC. © 2026 The Author(s). The Journal of Pathology published by John Wiley & Sons Ltd on behalf of The Pathological Society of Great Britain and Ireland.


Publication metadata

Author(s): O'Rourke JM, Kavanagh D, O'Keeffe A, Savoye K, Yang K, Patten DA, Willoughby CE, Llovet JM, Neag G, Reeves HL, Hewett PW, Kalia N, Shah T, Ma YT, Hunter K, Flint J, McMurray JL, Cain O, Spill F, Mann DA, Naylor AJ, Heath V, Weston CJ, Bicknell R, Shetty S

Publication type: Article

Publication status: Published

Journal: Journal of Pathology

Year: 2026

Pages: Epub ahead of print

Online publication date: 01/06/2026

Acceptance date: 15/04/2026

Date deposited: 15/06/2026

ISSN (print): 0022-3417

ISSN (electronic): 1096-9896

Publisher: John Wiley and Sons Ltd

URL: https://doi.org/10.1002/path.70077

DOI: 10.1002/path.70077

Data Access Statement: RNA sequencing data are available through the Gene Expression Omnibus: GSE253962 https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE253962


Altmetrics

Altmetrics provided by Altmetric


Funding

Funder referenceFunder name
Cancer Research UK Accelerator Award
Cancer Research UK Awards. Grant Number: C18342/A23390
Cancer Research UK Newcastle Centre. Grant Number: CTRQQR-2021\100003
Cancer Research UK. Grant Numbers: C18873/A26813, C53575/A29959
Engineering and Physical Sciences Research Council. Grant Number: EP/S02297X/1
Fondazione AIRC
European Commission. Grant Number: 101136622
Fundación Científica de la Asociación Española Contra el Cáncer. Grant Number: C9380/A26813
Generalitat de Catalunya. Grant Number: 2021-SGR 01347
NIH. Grant Numbers: R01-CA273932-01, RO1DK56621, RO1DK128289
Newcastle NIHR Biomedical Research Centre. Grant Number: NIHR203309
Spanish National Health Institute
Samuel Waxman Cancer Research Foundation
Versus Arthritis. Grant Number: 21743
Wellcome Trust Translational Development Fund

Share